<div>Alan Green presents the investment case.</div>

S1 Ep43: Research Talks - Castillo Copper & Destiny Pharma

<div>
<p><strong>Research Talks</strong> is a weekly podcast featuring independent market commentary from Mark Fairbairn, Daniel Flynn, and Alan Green. The show provides a non-company perspective on current market themes and stock opportunities, helping investors cut through the noise with clear, practical insights.</p>

<p>Each episode delivers third-party analysis, highlighting what matters most for investors and drawing out the key takeaways. <strong>Research Talks</strong> helps investors better understand the bigger picture and potential opportunities in the market.</p>

</div>

Business

Education

Self-Improvement

Investing

Research Talks is a weekly podcast featuring independent market commentary from Mark Fairbairn, Daniel Flynn, and Alan Green. The show provides a non-company perspective on current market themes and stock opportunities, helping investors cut through the noise with clear, practical insights. Each episode delivers third-party analysis, highlighting what matters most for investors and drawing out the key takeaways. Research Talks helps investors better understand the bigger picture and potential opportunities in the market.


<p><strong>Research Talks</strong> is a weekly podcast featuring independent market commentary from Mark Fairbairn, Daniel Flynn, and Alan Green. The show provides a non-company perspective on current market themes and stock opportunities, helping investors cut through the noise with clear, practical insights.</p>

<p>Each episode delivers third-party analysis, highlighting what matters most for investors and drawing out the key takeaways.&nbsp;<strong>Research Talks</strong> helps investors better understand the bigger picture and potential opportunities in the market.</p>



Share S1 Ep43: Research Talks - Castillo Copper & Destiny Pharma

Sign up to save your podcasts

S1 Ep43: Research Talks - Castillo Copper & Destiny Pharma

S1 Ep43: Research Talks - Castillo Copper & Destiny Pharma